TY - JOUR
T1 - Temporal Trends in Lipoprotein(a) Concentrations
T2 - The Atherosclerosis Risk in Communities Study
AU - Deshotels, Matthew R.
AU - Sun, Caroline
AU - Nambi, Vijay
AU - Virani, Salim S.
AU - Matsushita, Kunihiro
AU - Yu, Bing
AU - Ballantyne, Christie M.
AU - Hoogeveen, Ron C.
N1 - Publisher Copyright:
© 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
PY - 2022/11/1
Y1 - 2022/11/1
N2 - BACKGROUND: Plasma lipoprotein(a) (Lp[a]) concentrations are primarily determined by genetic factors and are believed to remain stable throughout life. However, data are scarce on longitudinal trends in Lp(a) concentrations over time. Therefore, it is unclear whether measurement of Lp(a) once in a person’s life is sufficient for cardiovascular risk assessment in all adults. METHODS AND RESULTS: Lp(a) concentrations, specifically apolipoprotein(a) concentrations, were measured at visits 4 and 5, ≈15 years apart, in 4734 adult participants of the ARIC (Atherosclerosis Risk in Communities) study (mean age at visits 4 and 5, 60.7±5.1 and 75.5±5.2 years, respectively). Participants were categorized by baseline (visit 4) Lp(a) concentrations as normal (<30 mg/dL), borderline-high (30– 49 mg/dL), or high (≥50 mg/dL). We compared adults with Lp(a) change ≥20 mg/dL between visits and those with Lp(a) change <20 mg/dL. Multivariable logistic regression analysis was used to identify covariates associated with change in Lp(a) over time. At visit 5, 58.1% of participants with borderline-high Lp(a) concentrations of 30 to 49 mg/ dL at visit 4 had high Lp(a) concentrations ≥50 mg/dL. Participants with low Lp(a) (<30 mg/dL) or high Lp(a) (≥50 mg/dL) at visit 4 tended to stay in these respective categories. Black race, female sex, diabetes, hypertension, total cholesterol, and albumi-nuria were associated with significantly greater probability for Lp(a) change ≥20 mg/dL over time. CONCLUSIONS: Our results suggest that adults with borderline-high Lp(a) concentrations may be considered for repeat moni-toring of Lp(a) over time, particularly if they are Black, women, or have diabetes, hypertension, and/or elevated albuminuria.
AB - BACKGROUND: Plasma lipoprotein(a) (Lp[a]) concentrations are primarily determined by genetic factors and are believed to remain stable throughout life. However, data are scarce on longitudinal trends in Lp(a) concentrations over time. Therefore, it is unclear whether measurement of Lp(a) once in a person’s life is sufficient for cardiovascular risk assessment in all adults. METHODS AND RESULTS: Lp(a) concentrations, specifically apolipoprotein(a) concentrations, were measured at visits 4 and 5, ≈15 years apart, in 4734 adult participants of the ARIC (Atherosclerosis Risk in Communities) study (mean age at visits 4 and 5, 60.7±5.1 and 75.5±5.2 years, respectively). Participants were categorized by baseline (visit 4) Lp(a) concentrations as normal (<30 mg/dL), borderline-high (30– 49 mg/dL), or high (≥50 mg/dL). We compared adults with Lp(a) change ≥20 mg/dL between visits and those with Lp(a) change <20 mg/dL. Multivariable logistic regression analysis was used to identify covariates associated with change in Lp(a) over time. At visit 5, 58.1% of participants with borderline-high Lp(a) concentrations of 30 to 49 mg/ dL at visit 4 had high Lp(a) concentrations ≥50 mg/dL. Participants with low Lp(a) (<30 mg/dL) or high Lp(a) (≥50 mg/dL) at visit 4 tended to stay in these respective categories. Black race, female sex, diabetes, hypertension, total cholesterol, and albumi-nuria were associated with significantly greater probability for Lp(a) change ≥20 mg/dL over time. CONCLUSIONS: Our results suggest that adults with borderline-high Lp(a) concentrations may be considered for repeat moni-toring of Lp(a) over time, particularly if they are Black, women, or have diabetes, hypertension, and/or elevated albuminuria.
KW - lipoprotein(a)
KW - risk assessment
KW - risk factors
UR - http://www.scopus.com/inward/record.url?scp=85141004075&partnerID=8YFLogxK
U2 - 10.1161/JAHA.122.026762
DO - 10.1161/JAHA.122.026762
M3 - Article
C2 - 36285784
AN - SCOPUS:85141004075
SN - 2047-9980
VL - 11
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 21
M1 - e026762
ER -